A citation-based method for searching scientific literature

Man Wang, Fei Yu, Yuan Zhang, Lei Zhang, Wenguang Chang, Kun Wang. Front Cell Dev Biol 2022
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vaccine Therapies for Cancer: Then and Now.
Michael A Morse, William R Gwin, Duane A Mitchell. Target Oncol 2021
31
33

Chimeric Antigen Receptor Therapy.
Carl H June, Michel Sadelain. N Engl J Med 2018
933
33

An overview of precision oncology basket and umbrella trials for clinicians.
Jay J H Park, Grace Hsu, Ellie G Siden, Kristian Thorlund, Edward J Mills. CA Cancer J Clin 2020
65
33


Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.
Ban Qi Tay, Quentin Wright, Rahul Ladwa, Christopher Perry, Graham Leggatt, Fiona Simpson, James W Wells, Benedict J Panizza, Ian H Frazer, Jazmina L G Cruz. Vaccines (Basel) 2021
11
33

Overcoming Chemotherapy Resistance in SCLC.
Brett H Herzog, Siddhartha Devarakonda, Ramaswamy Govindan. J Thorac Oncol 2021
11
33

Recombinant Viruses for Cancer Therapy.
Daria S Chulpanova, Valeriya V Solovyeva, Kristina V Kitaeva, Stephen P Dunham, Svetlana F Khaiboullina, Albert A Rizvanov. Biomedicines 2018
19
33

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.
Elizabeth A Mittendorf, Biao Lu, Michelle Melisko, Julie Price Hiller, Igor Bondarenko, Adrian Murray Brunt, Grybach Sergii, Katarina Petrakova, George E Peoples. Clin Cancer Res 2019
75
33

Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.
Cristina Gutierrez, Colleen McEvoy, Laveena Munshi, R Scott Stephens, Michael E Detsky, Joseph L Nates, Stephen M Pastores. Crit Care Med 2020
28
33



Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries.
Camillo Porta, Antonin Levy, Robert Hawkins, Daniel Castellano, Joaquim Bellmunt, Paul Nathan, Ray McDermott, John Wagstaff, Paul Donnellan, John McCaffrey,[...]. Cancer Med 2014
46
33

Molecular targeted therapy: Treating cancer with specificity.
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon. Eur J Pharmacol 2018
345
33

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, Jennifer N Brudno, Marcela V Maus, Jae H Park, Elena Mead, Steven Pavletic,[...]. Biol Blood Marrow Transplant 2019
33

New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.
Frank Kroschinsky, Friedrich Stölzel, Simone von Bonin, Gernot Beutel, Matthias Kochanek, Michael Kiehl, Peter Schellongowski. Crit Care 2017
218
33

Current Trends in Cancer Immunotherapy.
Ivan Y Filin, Valeriya V Solovyeva, Kristina V Kitaeva, Catrin S Rutland, Albert A Rizvanov. Biomedicines 2020
17
33

Epidermal growth factor receptor targeting in cancer.
John Mendelsohn, Jose Baselga. Semin Oncol 2006
521
33

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma.
Siler H Panowski, Tracy C Kuo, Yi Zhang, Amy Chen, Tao Geng, Laura Aschenbrenner, Cris Kamperschroer, Edward Pascua, Wei Chen, Kathy Delaria,[...]. Mol Cancer Ther 2019
15
33


Recent Advances in Oligonucleotide Therapeutics in Oncology.
Haoyu Xiong, Rakesh N Veedu, Sarah D Diermeier. Int J Mol Sci 2021
43
33

Therapeutic Advances in Oncology.
Jinsha Liu, Priyanka Pandya, Sepideh Afshar. Int J Mol Sci 2021
9
33

The Oncolytic Virus in Cancer Diagnosis and Treatment.
Guo-Dong Cao, Xiao-Bo He, Qiang Sun, Sihan Chen, Ke Wan, Xin Xu, Xudong Feng, Peng-Ping Li, Bo Chen, Mao-Ming Xiong. Front Oncol 2020
30
33

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J Schneider, Milan Anadkat, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau,[...]. J Clin Oncol 2021
37
33

Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.
Zhaoying Fu, Jim Xiang. Int J Mol Sci 2020
47
33

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
Gaurav Singal, Peter G Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M Frampton, Aracelis Z Torres, Erik M Lehnert,[...]. JAMA 2019
236
33

Pharmacovigilance in oncology.
Paolo Baldo, Giulia Fornasier, Laura Ciolfi, Ivana Sartor, Sara Francescon. Int J Clin Pharm 2018
23
33

Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
Lars Michel, Raluca I Mincu, Simone M Mrotzek, Sebastian Korste, Ulrich Neudorf, Tienush Rassaf, Matthias Totzeck. ESC Heart Fail 2020
20
33

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).
Raza M Alvi, Matthew J Frigault, Michael G Fradley, Michael D Jain, Syed S Mahmood, Magid Awadalla, Dae Hyun Lee, Daniel A Zlotoff, Lili Zhang, Zsofia D Drobni,[...]. J Am Coll Cardiol 2019
146
33



Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
M Hidalgo, L L Siu, J Nemunaitis, J Rizzo, L A Hammond, C Takimoto, S G Eckhardt, A Tolcher, C D Britten, L Denis,[...]. J Clin Oncol 2001
842
33


Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome.
Chelsea Kotch, David Barrett, David T Teachey. Expert Rev Clin Immunol 2019
147
33

Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success.
Marina Elena Cazzaniga, Romano Danesi, Corrado Girmenia, Pietro Invernizzi, Alessandra Elvevi, Massimo Uguccioni. Breast Cancer Res Treat 2019
20
33


Highlights in Resistance Mechanism Pathways for Combination Therapy.
João M A Delou, Alana S O Souza, Leonel C M Souza, Helena L Borges. Cells 2019
28
33

Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
Brandon Douglas Brown, Francesco Paolo Tambaro, Mira Kohorst, Linda Chi, Kris Michael Mahadeo, Priti Tewari, Demetrios Petropoulos, John M Slopis, Zsila Sadighi, Sajad Khazal. Front Oncol 2021
10
33

Theranostic potential of oncolytic vaccinia virus.
Juan J Rojas, Steve H Thorne. Theranostics 2012
22
33

Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
Shuya Yano, Hiroshi Tazawa, Hiroyuki Kishimoto, Shunsuke Kagawa, Toshiyoshi Fujiwara, Robert M Hoffman. Int J Mol Sci 2021
5
33

Turning the corner on therapeutic cancer vaccines.
Robert E Hollingsworth, Kathrin Jansen. NPJ Vaccines 2019
304
33

Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Tao Shi, Xueru Song, Yue Wang, Fangcen Liu, Jia Wei. Front Immunol 2020
61
33

Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis.
Avirup Guha, Daniel Addison, Prantesh Jain, Jahir M Gutierrez, Arjun Ghosh, Claire Roddie, Marcos de Lima, Sadeer Al-Kindi, Guilherme H Oliveira. Biol Blood Marrow Transplant 2020
22
33

Novel points of attack for targeted cancer therapy.
Gro Vatne Røsland, Agnete Svendsen Tenfjord Engelsen. Basic Clin Pharmacol Toxicol 2015
32
33

Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China.
Ruofei Du, Xin Wang, Lixia Ma, Leon M Larcher, Han Tang, Huiyue Zhou, Changying Chen, Tao Wang. BMC Cancer 2021
9
33

The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer.
Dhruvajyoti Roy, Andreas Pascher, Mazen A Juratli, Judith C Sporn. Int J Mol Sci 2021
11
33

Serious adverse effects occurring after chemotherapy: A general cancer registry-based incidence survey.
Isabelle Ingrand, Gautier Defossez, Claire Lafay-Chebassier, François Chavant, Aurélie Ferru, Pierre Ingrand, Marie-Christine Pérault-Pochat. Br J Clin Pharmacol 2020
7
33


T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road.
Michael D Crowther, Inge Marie Svane, Özcan Met. Cells 2020
13
33


Oncolytic Virotherapy for Cancer: Clinical Experience.
Shyambabu Chaurasiya, Yuman Fong, Susanne G Warner. Biomedicines 2021
17
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.